[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Fahrmann et al., 2020 - Google Patents

Plasma-derived extracellular vesicles convey protein signatures that reflect pathophysiology in lung and pancreatic adenocarcinomas

Fahrmann et al., 2020

View HTML
Document ID
1381857878113643991
Author
Fahrmann J
Mao X
Irajizad E
Katayama H
Capello M
Tanaka I
Kato T
Wistuba I
Maitra A
Ostrin E
Hanash S
Vykoukal J
Publication year
Publication venue
Cancers

External Links

Snippet

Using a combination of mass-spectrometry and aptamer array-based proteomics, we characterized the protein features of circulating extracellular vesicles (EVs) in the context of lung (LUAD) and pancreatic ductal (PDAC) adenocarcinomas. We profiled EVs isolated from …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means

Similar Documents

Publication Publication Date Title
Logozzi et al. Exosomes: a source for new and old biomarkers in cancer
Smolarz et al. Proteome profiling of exosomes purified from a small amount of human serum: the problem of co-purified serum components
Bianchi et al. TLR3 expression induces apoptosis in human non-small-cell lung cancer
Zeng et al. Proteomic analysis identified DJ-1 as a cisplatin resistant marker in non-small cell lung cancer
Fahrmann et al. Plasma-derived extracellular vesicles convey protein signatures that reflect pathophysiology in lung and pancreatic adenocarcinomas
Beccard et al. Immune suppressive effects of plasma-derived exosome populations in head and neck cancer
Shaba et al. Multi-omics integrative approach of extracellular vesicles: a future challenging milestone
Konoshenko et al. Total blood exosomes in breast cancer: Potential role in crucial steps of tumorigenesis
Fahrmann et al. Mutational activation of the NRF2 pathway upregulates kynureninase resulting in tumor immunosuppression and poor outcome in lung adenocarcinoma
Paolino et al. The fatty acid and protein profiles of circulating CD81-positive small extracellular vesicles are associated with disease stage in melanoma patients
Repetto et al. Proteomic exploration of plasma exosomes and other small extracellular vesicles in pediatric hodgkin lymphoma: a potential source of biomarkers for relapse occurrence
Lavoie et al. Surfaceome profiling of rhabdomyosarcoma reveals B7-H3 as a mediator of immune evasion
Jeong et al. GCC2 as a new early diagnostic biomarker for non-small cell lung cancer
Zebrowska et al. Proteomic and metabolomic profiles of T cell-derived exosomes isolated from human plasma
Zhang et al. Proteomics, phosphoproteomics and mirna analysis of circulating extracellular vesicles through automated and high-throughput isolation
Li et al. Glycoproteomic analysis of urinary extracellular vesicles for biomarkers of hepatocellular carcinoma
Lai et al. Protein panel of serum-derived small extracellular vesicles for the screening and diagnosis of epithelial ovarian cancer
Wu et al. Discovery of spatial peptide signatures for neuroblastoma risk assessment by MALDI mass spectrometry imaging
Ramqvist et al. Protein expression in tonsillar and base of tongue cancer and in relation to human papillomavirus (HPV) and clinical outcome
Brocco et al. High blood concentration of leukocyte-derived extracellular vesicles is predictive of favorable clinical outcomes in patients with pancreatic cancer: Results from a multicenter prospective study
Vetsika et al. Small extracellular vesicles in pre-therapy plasma predict clinical outcome in non-small-cell lung cancer patients
Nair et al. miR-18a mediates immune evasion in ER-positive breast cancer through Wnt signaling
Sanwald et al. The GABARAP co-secretome identified by APEX2-GABARAP proximity labelling of extracellular vesicles
Marconi et al. Trastuzumab modulates the protein cargo of extracellular vesicles released by erbb2+ breast cancer cells
Głuszko et al. Small extracellular vesicles from head and neck squamous cell carcinoma cells carry a proteomic signature for tumor hypoxia